title: "Strong reasons make strong actions"--The antiviral efficacy of NS3/4A protease inhibitors.
authors.affiliation: Center for Hepatitis Research, Institute for Human Infections & Immunity, University of Texas Medical Branch, Galveston, TX, USA.
authors.forename: Stanley M
authors.initials: SM
authors.lastname: Lemon
authors.forename: Minkyung
authors.initials: M
authors.lastname: Yi
authors.forename: Kui
authors.initials: K
authors.lastname: Li
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D002219:Carbamates / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D004311:Double-Blind Method; D024882:Drug Resistance, Viral; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D047028:Macrocyclic Compounds / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D011804:Quinolines / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D012367:RNA, Viral / Q000032:analysis; D015842:Serine Proteinase Inhibitors / Q000627:therapeutic use*; D013844:Thiazoles / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D017361:Viral Nonstructural Proteins / Q000037:antagonists & inhibitors*; D012697:Serine Endopeptidases; D043583:Nucleoside-Triphosphatase; D053487:DEAD-box RNA Helicases; D000085242:Viral Proteases
chemical_list: D000998:Antiviral Agents; D002219:Carbamates; D047028:Macrocyclic Compounds; D011804:Quinolines; D012367:RNA, Viral; D015842:Serine Proteinase Inhibitors; D013844:Thiazoles; D017361:Viral Nonstructural Proteins; C479555:BILN 2061; C084422:NS3 protein, hepatitis C virus; D012697:Serine Endopeptidases; D043583:Nucleoside-Triphosphatase; D053487:DEAD-box RNA Helicases; D000085242:Viral Proteases; C093542:NS4 protein, hepatitis C virus